Src and NF-kB have been repeatedly implicated as poor prognostic factors in many cancers, including triple negative breast cancer, and we found that their upregulation has been shown to decrease patient survival in GBM (Figure 1a,b) [12]. Here, NFKB1 is linked to glioblastoma.